BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 35939608)

  • 21. Association of Self-reported COVID-19 Infection and SARS-CoV-2 Serology Test Results With Persistent Physical Symptoms Among French Adults During the COVID-19 Pandemic.
    Matta J; Wiernik E; Robineau O; Carrat F; Touvier M; Severi G; de Lamballerie X; Blanché H; Deleuze JF; Gouraud C; Hoertel N; Ranque B; Goldberg M; Zins M; Lemogne C;
    JAMA Intern Med; 2022 Jan; 182(1):19-25. PubMed ID: 34747982
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Determinants and Dynamics of SARS-CoV-2 Infection in a Diverse Population: 6-Month Evaluation of a Prospective Cohort Study.
    Horton DB; Barrett ES; Roy J; Gennaro ML; Andrews T; Greenberg P; Bruiners N; Datta P; Ukey R; Velusamy SK; Fine D; Honnen WJ; Yin YS; Pinter A; Brooks A; Tischfield J; Hussain S; Jagpal S; Swaminathan S; Parmar V; Reilly N; Gaur S; Panettieri RA; Carson JL; Blaser MJ
    J Infect Dis; 2021 Oct; 224(8):1345-1356. PubMed ID: 34387310
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Human and novel coronavirus infections in children: a review.
    Rajapakse N; Dixit D
    Paediatr Int Child Health; 2021 Feb; 41(1):36-55. PubMed ID: 32584199
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Quantitative SARS-CoV-2 Serology in Children With Multisystem Inflammatory Syndrome (MIS-C).
    Rostad CA; Chahroudi A; Mantus G; Lapp SA; Teherani M; Macoy L; Tarquinio KM; Basu RK; Kao C; Linam WM; Zimmerman MG; Shi PY; Menachery VD; Oster ME; Edupuganti S; Anderson EJ; Suthar MS; Wrammert J; Jaggi P
    Pediatrics; 2020 Dec; 146(6):. PubMed ID: 32879033
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Detection of Serum Cross-Reactive Antibodies and Memory Response to SARS-CoV-2 in Prepandemic and Post-COVID-19 Convalescent Samples.
    Shrwani K; Sharma R; Krishnan M; Jones T; Mayora-Neto M; Cantoni D; Temperton NJ; Dobson SL; Subramaniam K; McNamara PS; Cunliffe NA; Turtle L; Zhang Q
    J Infect Dis; 2021 Oct; 224(8):1305-1315. PubMed ID: 34161567
    [TBL] [Abstract][Full Text] [Related]  

  • 26. IgG antibody titers against SARS-CoV-2 nucleocapsid protein correlate with the severity of COVID-19 patients.
    Yang L; Xu Q; Yang B; Li J; Dong R; Da J; Ye Z; Xu Y; Zhou H; Zhang X; Liu L; Zha Y; Yu F
    BMC Microbiol; 2021 Dec; 21(1):351. PubMed ID: 34922455
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Are SARS-CoV-2 Antibodies Detectable in Human Milk After Vaccination Against COVID-19?
    Scaggs Huang F
    J Pediatric Infect Dis Soc; 2022 Apr; 11(4):126. PubMed ID: 35394545
    [TBL] [Abstract][Full Text] [Related]  

  • 28. SARS-CoV-2 Virus-Like Particle Neutralizing Capacity in Blood Donors Depends on Serological Profile and Donor-Declared SARS-CoV-2 Vaccination History.
    Drews SJ; Hu Q; Samson R; Abe KT; Rathod B; Colwill K; Gingras AC; Yi QL; O'Brien SF
    Microbiol Spectr; 2022 Feb; 10(1):e0226221. PubMed ID: 35171006
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mild SARS-CoV-2 Illness Is Not Associated with Reinfections and Provides Persistent Spike, Nucleocapsid, and Virus-Neutralizing Antibodies.
    Schuler CF; Gherasim C; O'Shea K; Manthei DM; Chen J; Zettel C; Troost JP; Kennedy AA; Tai AW; Giacherio DA; Valdez R; Baldwin JL; Baker JR
    Microbiol Spectr; 2021 Oct; 9(2):e0008721. PubMed ID: 34468184
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A Prospective Cohort Study in Nonhospitalized Household Contacts With Severe Acute Respiratory Syndrome Coronavirus 2 Infection: Symptom Profiles and Symptom Change Over Time.
    Yousaf AR; Duca LM; Chu V; Reses HE; Fajans M; Rabold EM; Laws RL; Gharpure R; Matanock A; Wadhwa A; Pomeroy M; Njuguna H; Fox G; Binder AM; Christiansen A; Freeman B; Gregory C; Tran CH; Owusu D; Ye D; Dietrich E; Pevzner E; Conners EE; Pray I; Rispens J; Vuong J; Christensen K; Banks M; O'Hegarty M; Mills L; Lester S; Thornburg NJ; Lewis N; Dawson P; Marcenac P; Salvatore P; Chancey RJ; Fields V; Buono S; Yin S; Gerber S; Kiphibane T; Dasu T; Bhattacharyya S; Westergaard R; Dunn A; Hall AJ; Fry AM; Tate JE; Kirking HL; Nabity S
    Clin Infect Dis; 2021 Oct; 73(7):e1841-e1849. PubMed ID: 32719874
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Humoral and cellular immune responses to Pfizer-BioNTech BNT162b2 SARS-CoV-2 vaccine in adolescents with liver transplantation: Single center experience.
    Sánchez-Zapardiel E; Alós M; Nozal P; González-Muñoz M; Frauca-Remacha E; Gavilán LB; Quiles MJ; Hierro L; López-Granados E
    Front Immunol; 2022; 13():1049188. PubMed ID: 36505469
    [TBL] [Abstract][Full Text] [Related]  

  • 32. SARS-CoV-2 seropositivity and subsequent infection risk in healthy young adults: a prospective cohort study.
    Letizia AG; Ge Y; Vangeti S; Goforth C; Weir DL; Kuzmina NA; Balinsky CA; Chen HW; Ewing D; Soares-Schanoski A; George MC; Graham WD; Jones F; Bharaj P; Lizewski RA; Lizewski SE; Marayag J; Marjanovic N; Miller CM; Mofsowitz S; Nair VD; Nunez E; Parent DM; Porter CK; Santa Ana E; Schilling M; Stadlbauer D; Sugiharto VA; Termini M; Sun P; Tracy RP; Krammer F; Bukreyev A; Ramos I; Sealfon SC
    Lancet Respir Med; 2021 Jul; 9(7):712-720. PubMed ID: 33865504
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effectiveness of mRNA-1273, BNT162b2, and BBIBP-CorV vaccines against infection and mortality in children in Argentina, during predominance of delta and omicron covid-19 variants: test negative, case-control study.
    Castelli JM; Rearte A; Olszevicki S; Voto C; Del Valle Juarez M; Pesce M; Iovane AN; Paz M; Chaparro ME; Buyayisqui MP; Markiewicz MB; Landoni M; Giovacchini CM; Vizzotti C
    BMJ; 2022 Nov; 379():e073070. PubMed ID: 36450402
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development of a SARS-CoV-2 Total Antibody Assay and the Dynamics of Antibody Response over Time in Hospitalized and Nonhospitalized Patients with COVID-19.
    Vogelzang EH; Loeff FC; Derksen NIL; Kruithof S; Ooijevaar-de Heer P; van Mierlo G; Linty F; Mok JY; van Esch W; de Bruin S; Vlaar APJ; ; Seppen B; Leeuw M; van Oudheusden AJG; Buiting AGM; Jim KK; Vrielink H; Swaneveld F; Vidarsson G; van der Schoot CE; Wever PC; Li W; van Kuppeveld F; Murk JL; Bosch BJ; Wolbink GJ; Rispens T
    J Immunol; 2020 Dec; 205(12):3491-3499. PubMed ID: 33127820
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Kinetics of anti-SARS-CoV-2 antibody titer in healthy adults up to 6 months after BNT162b2 vaccination measured by two immunoassays: A prospective cohort study in Japan.
    Matsuura T; Fukushima W; Nakagama Y; Kido Y; Kase T; Kondo K; Kaku N; Matsumoto K; Suita A; Komiya E; Mukai E; Nitahara Y; Konishi A; Kasamatsu A; Nakagami-Yamaguchi E; Ohfuji S; Kaneko Y; Kaneko A; Kakeya H; Hirota Y
    Vaccine; 2022 Sep; 40(38):5631-5640. PubMed ID: 36028457
    [TBL] [Abstract][Full Text] [Related]  

  • 36. SARS-CoV-2 seroepidemiology in paediatric population during Delta and Omicron predominance.
    Filippatos F; Tatsi EB; Dellis C; Koukou DM; Papagiannopoulos C; Margeli A; Siahanidou T; Kanaka-Gantenbein C; Syriopoulou V; Michos A
    Epidemiol Infect; 2022 Oct; 150():e177. PubMed ID: 36345855
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dynamics in COVID-19 symptoms during different waves of the pandemic among children infected with SARS-CoV-2 in the ambulatory setting.
    Ben-Tov A; Lotan R; Gazit S; Chodick G; Perez G; Mizrahi-Reuveni M; Patalon T
    Eur J Pediatr; 2022 Sep; 181(9):3309-3318. PubMed ID: 35778524
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serological Assays for Assessing Postvaccination SARS-CoV-2 Antibody Response.
    Mahmoud SA; Ganesan S; Naik S; Bissar S; Zamel IA; Warren KN; Zaher WA; Khan G
    Microbiol Spectr; 2021 Oct; 9(2):e0073321. PubMed ID: 34585943
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Seroprevalence of SARS-CoV-2 in Children During Early COVID-19 Pandemic in Korea: A Nationwide, Population-Based Study.
    Lee J; Choe YJ; Minn D; Kim JH
    J Korean Med Sci; 2022 Nov; 37(44):e314. PubMed ID: 36377292
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Persistent symptoms after COVID-19 in children and adolescents from Argentina.
    Seery V; Raiden S; Penedo JMG; Borda M; Herrera L; Uranga M; Marcó Del Pont M; Chirino C; Erramuspe C; Alvarez LS; Lenoir M; Morales LD; Davenport C; Huespe Auchter S; Monsalvo L; Sastoque L; Gavazzi M; Russo C; Sananez I; Pando MLÁ; Laufer N; Muiños R; Ferrero F; Geffner J; Arruvito L
    Int J Infect Dis; 2023 Apr; 129():49-56. PubMed ID: 36736574
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.